Covered recipient · General Payments record
HEATHER D ROGERS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$4,429.92
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $729.69 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.80 | 12 |
| Galderma Laboratories, L.P. | $192.24 | 2 |
| GENZYME CORPORATION | $131.00 | 8 |
| REVANCE THERAPEUTICS, INC. | $103.50 | 2 |
| Incyte Corporation | $38.41 | 2 |
| ORGANOGENESIS INC. | $31.59 | 2 |
| UCB, Inc. | $13.66 | 1 |
| Arcutis Biotherapeutics, Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.69 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966916 | CMS |
| ABBVIE INC. | $18.17 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966918 | CMS |
| ABBVIE INC. | $13.75 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966920 | CMS |
| ABBVIE INC. | $15.29 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966922 | CMS |
| ABBVIE INC. | $18.84 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966924 | CMS |
| ABBVIE INC. | $8.22 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966926 | CMS |
| ABBVIE INC. | $22.06 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966928 | CMS |
| ABBVIE INC. | $22.86 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966930 | CMS |
| ABBVIE INC. | $20.90 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966932 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966934 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966936 | CMS |
| ABBVIE INC. | $23.44 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105966938 | CMS |
| Arcutis Biotherapeutics, Inc. | $13.49 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121049531 | CMS |
| Galderma Laboratories, L.P. | $22.53 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145324477 | CMS |
| Galderma Laboratories, L.P. | $169.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145324479 | CMS |
| GENZYME CORPORATION | $13.95 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933123 | CMS |
| GENZYME CORPORATION | $14.56 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933159 | CMS |
| GENZYME CORPORATION | $9.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933185 | CMS |
| GENZYME CORPORATION | $23.87 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933199 | CMS |
| GENZYME CORPORATION | $31.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933211 | CMS |
| GENZYME CORPORATION | $12.76 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933225 | CMS |
| GENZYME CORPORATION | $12.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933231 | CMS |
| GENZYME CORPORATION | $12.68 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933267 | CMS |
| Incyte Corporation | $24.00 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141189601 | CMS |
| Incyte Corporation | $14.41 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141247780 | CMS |
| Organogenesis Inc. | $14.35 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145444729 | CMS |
| Organogenesis Inc. | $17.24 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145444731 | CMS |
| REVANCE THERAPEUTICS, INC. | $55.11 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927787 | CMS |
| REVANCE THERAPEUTICS, INC. | $48.39 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147927789 | CMS |
| UCB, Inc. | $13.66 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143437649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.